Impact of Shenling Baizhu Powder on lipid profiles and body mass index in breast cancer patients under adjuvant chemotherapy: a retrospective study
Chemotherapy increased the TC, TG, LDL-C, and ApoB levels in breast cancer patients, but SLBZP mitigated dyslipidemia. The patients who received SLBZP also showed increased BMI post-chemotherapy, which was likely due to reduced gastrointestinal side effects. Taxane-based chemotherapy drugs had greater effects on blood lipids and BMI, while anthracycline-based drugs did not significantly affect blood lipids and BMI.
Authors
- Marcelo Antonini (ORCID: https://orcid.org/0000-0002-1996-7428)
- Xiufei Gao (ORCID: https://orcid.org/0000-0002-2560-7920)
- Jiaqing Song (ORCID: https://orcid.org/0000-0002-8281-407X)
- Geok Hoon Lim (ORCID: https://orcid.org/0000-0002-5296-3437)
- Hongting Wu (ORCID: https://orcid.org/0009-0006-3730-4560)
- Ying Jin (ORCID: https://orcid.org/0009-0003-8208-1149)
- Hailong Li (ORCID: https://orcid.org/0000-0001-7781-6815)
- Qinghong Yu (ORCID: https://orcid.org/0000-0003-0710-8383)
Institutions
- Zhejiang Chinese Medical University (CN)
- KK Women's and Children's Hospital (SG)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.21037/tcr-2024-2658
- Citations
- 2
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.87